Efficacy of phloroglucinol for treatment of abdominal pain: a systematic review of literature and meta-analysis of randomised controlled trials versus placebo Clara BlanchardDenis PouchainHélène Vaillant-Roussel Review 19 January 2018 Pages: 541 - 548
A comparison of group sequential and fixed sample size designs for bioequivalence trials with highly variable drugs Sophie I. E. KnahlBenjamin LangMeinhard Kieser Clinical Trial 23 January 2018 Pages: 549 - 559
Evaluation of pharmacokinetic and pharmacodynamic parameters following single dose of sitagliptin in healthy Indian males Ganesh V. SangleMohan PatilP. Aravindababu Pharmacodynamics 06 March 2018 Pages: 561 - 569
Pharmacokinetic and pharmacodynamic re-evaluation of a genetic-guided warfarin trial Carlo Federico ZambonVittorio PengoRoberto Padrini Pharmacogenetics 02 February 2018 Pages: 571 - 582
Population pharmacokinetics of lamotrigine co-administered with valproic acid in Chinese epileptic children using nonlinear mixed effects modeling Shansen XuLimin LiuLimei Zhao Pharmacokinetics and Disposition 16 January 2018 Pages: 583 - 591
Determination of plasma concentration reference ranges for oral aripiprazole, olanzapine, and quetiapine Julia KorellBruce GreenAn Vermeulen Pharmacokinetics and Disposition 01 February 2018 Pages: 593 - 599
Lack of pharmacokinetic interaction between fluvastatin and green tea in healthy volunteers Shingen MisakaOsamu AbeJunko Kimura Pharmacokinetics and Disposition 24 January 2018 Pages: 601 - 609
Residual rivaroxaban exposure after discontinuation of anticoagulant therapy in patients undergoing cardiac catheterization Martin H. J. WiesenCornelia BlaichGuido Michels Pharmacokinetics and Disposition 28 January 2018 Pages: 611 - 618
Antipsychotics use: 2006–2013 trends in prevalence and incidence and characterization of users François MontastrucAnne Bénard-LaribièreAntoine Pariente Pharmacoepidemiology and Prescription 06 January 2018 Pages: 619 - 626
Reported time to onset of neurological adverse drug reactions among different age and gender groups using metoclopramide: an analysis of the global database Vigibase®. Kristian SvendsenMollie WoodHedvig Nordeng Pharmacoepidemiology and Prescription 30 December 2017 Pages: 627 - 636
NSAIDs utilization for musculoskeletal indications in elderly patients with cerebro/cardiovascular disease Giuseppe RobertoClaudia Bartolinion behalf of the Italian Group for Appropriate Drug prescription in the Elderly (I-GrADE) Pharmacoepidemiology and Prescription Open access 30 January 2018 Pages: 637 - 643
Potentially inappropriate medications in community-dwelling older adults undertaken as a comprehensive geriatric risk assessment Sharmin S. BalaSujita W. NarayanPrasad S. Nishtala Pharmacoepidemiology and Prescription 12 January 2018 Pages: 645 - 653
The nocebo effect challenges the non-medical infliximab switch in practice N. W. BooneL. LiuA. A. van Bodegraven Pharmacoepidemiology and Prescription Open access 24 January 2018 Pages: 655 - 661
The changing multiple sclerosis treatment landscape: impact of new drugs and treatment recommendations Irene ErikssonJoris KomenMia von Euler Pharmacoepidemiology and Prescription Open access 10 February 2018 Pages: 663 - 670
Advantage of landiolol over esmolol? We doubt it! Guenther FrankRobert Denham Fitzgerald Letter to the Editor 08 January 2018 Pages: 671 - 672
Answering letter to remark of Dr’s Frank and Fitzgerald Günther Krumpl Letter to the Editor 10 January 2018 Pages: 673 - 674
Subtherapeutic valproic acid plasma concentrations under concomitant dipyrone therapy in an epilepsy patient—a case report Benedict MorathK. GreenT. Hoppe-Tichy Letter to the Editor 23 January 2018 Pages: 675 - 677